| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.40B | 32.71B | 29.05B | 28.12B | 22.93B | 24.74B |
| Gross Profit | 6.11B | 6.48B | 5.77B | 5.38B | 4.04B | 3.45B |
| EBITDA | 2.36B | 2.50B | 2.02B | 1.31B | -53.20M | -424.38M |
| Net Income | 1.35B | 1.37B | 1.05B | 759.51M | -811.86M | -1.02B |
Balance Sheet | ||||||
| Total Assets | 22.74B | 28.30B | 23.65B | 23.88B | 21.63B | 21.87B |
| Cash, Cash Equivalents and Short-Term Investments | 3.88B | 4.38B | 3.88B | 2.88B | 2.12B | 3.55B |
| Total Debt | 4.96B | 5.41B | 5.53B | 6.58B | 7.15B | 6.78B |
| Total Liabilities | 13.75B | 17.31B | 14.76B | 15.89B | 15.05B | 14.46B |
| Stockholders Equity | 7.17B | 9.01B | 7.05B | 6.33B | 5.10B | 6.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 744.82M | 2.37B | 1.47B | -1.75B | -1.69B |
| Operating Cash Flow | 0.00 | 1.68B | 2.78B | 1.64B | -1.52B | -1.10B |
| Investing Cash Flow | 0.00 | -1.03B | -493.26M | -277.88M | -276.20M | -1.07B |
| Financing Cash Flow | 0.00 | -154.83M | -1.28B | -604.03M | 367.89M | 2.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥8.11B | 2.01 | ― | 0.53% | 12.61% | 29.41% | |
68 Neutral | ¥28.56B | 6.45 | 14.95% | 0.77% | 1.57% | -2.93% | |
68 Neutral | ¥250.27B | 10.38 | 12.24% | 2.31% | -6.81% | 72.30% | |
68 Neutral | ¥42.88B | 17.96 | ― | 4.43% | -0.53% | -31.86% | |
67 Neutral | ¥42.90B | 7.02 | ― | 2.93% | -1.36% | -9.69% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | ¥36.90B | 26.36 | ― | 2.26% | 0.63% | -60.75% |